| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2015-06-09 | Amag Pharmaceuticals (USA - MA) | nomination |
Nomination | |||
| 2015-06-09 | Cerenis Therapeutics (USA) | nomination |
Cardiovascular diseases - Metabolic diseases | Nomination | ||
| 2015-06-09 | PEP Therapy (France) CleveXel Pharma (France) | targeted therapeutic peptide | developement |
Cancer - Oncology | Development agreement | |
| 2015-06-08 | Seattle Genetics (USA - WA) Unum Therapeutics (USA - MA) | antibody-coupled T-cell receptor (ACTR) therapies | collaboration licensing |
Cancer - Oncology | Licensing agreement | |
| 2015-06-08 | Amicus Therapeutics (USA - NJ) | nomination |
Rare diseases - Genetic diseases | Nomination | ||
| 2015-06-08 | PlasmaTech Biopharmaceuticals, now Abeona Therapeutics (USA - NY) UNeMed Corporation (USA - NE) University of Nebraska Medical Center (USA - NE) | adeno-associated virus (AAV) gene therapy program | juvenile Batten disease | licensing |
Rare diseases - Neurodegenerative diseases - Genetic diseases | Licensing agreement |
| 2015-06-08 | Hemofarm (Serbia) Stada (Germany) | opening of new premises |
Opening of new premises | |||
| 2015-06-08 | Alnylam Therapeutics (USA - MA) | nomination |
Nomination | |||
| 2015-06-08 | Novasep (France) Allied Laboratories (Japan) | distribution collaboration |
Technology - Services | Distribution agreement | ||
| 2015-06-08 | Novasep (France) AR Brown (Japan) | distribution collaboration |
Technology - Services | Distribution agreement | ||
| 2015-06-08 | Merck KGaA (Germany) Merck Serono (Germany) Illumina (USA - CA) Genea (Australia) | Global Fertility Alliance | collaboration |
Fertility - Women health | Collaboration agreement | |
| 2015-06-05 | Fate Therapeutics (USA - CA) Boston Children\'s Hospital (USA - MA) | adoptive immunoregulatory cell therapy including PD-L1 programmed CD34+ cell | type 1 diabetes | development |
Autoimmune diseases | Development agreement |
| 2015-06-04 | Ultragenyx Pharmaceutical (USA - CA) | nomination |
Rare diseases | Nomination | ||
| 2015-06-04 | Novozymes (Denmark) | construction of new premises |
Construction of new premises | |||
| 2015-06-03 | The Lead Discovery Center (LDC) (Germany) Qurient (South Korea) | CDK7 inhibitors | collaboration development |
Cancer - Oncology - Infectious diseases - Inflammatory diseases | Development agreement | |
| 2015-06-03 | AmpliPhi BioSciences (USA - VA) | validation of a production plant |
Infectious diseases | Validation of a production plant | ||
| 2015-06-03 | Affimed (Germany) | nomination |
Cancer - Oncology | Nomination | ||
| 2015-06-03 | Takeda Pharmaceutical (Japan) | vaccine business | restructuring |
Infectious diseases | Restructuring | |
| 2015-06-03 | Agenus (USA - MA) Merck&Co (USA - NJ) | therapeutic antibodies to Merck proprietary immune checkpoints | R&D |
Cancer - Oncology | R&D agreement | |
| 2015-06-03 | Genvec (USA - MD) Washington University School of Medicine (USA - MO) | vaccines based on modified versions of GenVec's gorilla adenovectors incorporating camelid antibodies | collaboration |
Collaboration agreement |
